InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Koenig Sheldon L., Chairman & CEO. Officer active across 1 companies, notably Esperion Therapeutics, Inc.. Cumulatively, 7 reports have been published. Total volume traded: €24k. The latest transaction was disclosed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€21,5414,552 shares@ €4.73220.0027% mcap90.1% of flow
Common Stock
SEC:0001628280-22-017642:0·
€2,373571 shares@ €4.15530.0003% mcap9.9% of flow
Common Stock
SEC:0001628280-22-006733:0·
0116,000 shares0
Common Stock
SEC:0001628280-22-006405:0·
026,700 shares0
Common Stock
SEC:0001628280-21-021009·
026,700 shares0
Common Stock
SEC:0001628280-21-021009:0·
020,000 shares0
Common Stock
SEC:0001628280-21-010605·
020,000 shares0
Common Stock
SEC:0001628280-21-010605:0·
7 of 7 declarations
About Koenig Sheldon L.
Koenig Sheldon L. is the President and CEO of Esperion Therapeutics, Inc. He leads the company by overseeing operations and defining the business strategy. Koenig is responsible for innovation and the development of new treatments, thereby contributing to Esperion's mission of transforming patients' lives. His leadership is essential in achieving the company's growth and research objectives.
